{"nct_id":"NCT05722418","title":"CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2023-02-06","start_date_type":"ACTUAL","primary_completion_date":"2027-12","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["CRBU"]}